Finance

Beta
Lists
INVA:NASDAQ
Innoviva Inc
$22.52
+1.62%
(+0.36) 1D
$22.52
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INVA...
Open
$22.46
High
$22.93
Low
$22.41
Mkt. cap
1.66B
Avg. vol.
791.65K
Volume
845.41K
P/E ratio
3.73
52-wk high
$25.14
52-wk low
$16.52
EPS
$6.04
Beta
0.35
Shares outstanding
73.81M
No. of employees
159
Open
$22.46
High
$22.93
Low
$22.41
Mkt. cap
1.66B
Avg. vol.
791.65K
Volume
845.41K
P/E ratio
3.73
52-wk high
$25.14
52-wk low
$16.52
EPS
$6.04
Beta
0.35
Shares outstanding
73.81M
No. of employees
159
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to INVA in the past 3 months
Buy
Buy
3
Hold
0
Sell
1
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for INVA in the last 3 months.
Highest
Current $22.52
$46.00 (+104.26%)
Average
$34.50 (+53.20%)
Lowest
$18.00 (-20.07%)
News stories
From sources across the web
About Innoviva Inc
CEO-
Employees159
Founded1996
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Websiteinva.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.47 / $0.43
+8.79%beat
Revenue / Est. (USD)
97.99M / 101.46M
-3.41%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
100.28M
107.80M
114.61M
97.99M
Cost of goods sold
10.59M
35.69M
36.18M
14.46M
Cost of revenue
10.59M
35.69M
36.18M
14.46M
Research and development expenses
7.98M
-
-
5.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.41M
27.41M
32.08M
32.44M
Operating expense
40.94M
34.03M
38.71M
44.23M
Total operating expenses
51.53M
69.72M
74.89M
58.69M
Operating income
48.75M
38.08M
39.72M
39.30M
Other non operating income
-777.00K
-479.00K
-612.00K
-366.00K
EBT including unusual items
72.60M
97.82M
195.04M
234.56M
EBT excluding unusual items
48.24M
39.06M
41.95M
44.49M
Income tax expense
8.91M
7.91M
30.88M
47.97M
Effective tax rate
12.27%
8.09%
15.83%
20.45%
Other operating expenses
-
-
-
-
Net income
63.69M
89.91M
164.15M
186.60M
Net profit margin
63.51%
83.40%
143.22%
190.41%
Earnings per share
-
0.38
0.47
0.47
Interest and investment income
4.92M
5.47M
6.15M
10.99M
Interest expense
-4.66M
-4.02M
-3.31M
-5.44M
Net interest expenses
262.00K
1.46M
2.84M
5.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
55.33M
44.73M
46.39M
45.89M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer